For: | Iyer LR, Banyal N, Naik S, Paul J. Antioxidant enzyme profile of two clinical isolates of Entamoeba histolytica varying in sensitivity to antiamoebic drugs. World J Clin Infect Dis 2017; 7(2): 21-31 [DOI: 10.5495/wjcid.v7.i2.21] |
---|---|
URL: | https://www.wjgnet.com/2220-3176/full/v7/i2/21.htm |
Number | Citing Articles |
1 |
Anjan Debnath, Mario Alberto Rodriguez, Serge Ankri. Editorial: Recent Progresses in Amebiasis. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00247
|
2 |
Kentaro Kato, Mitsumasa Miura, Hiroshi Tachibana, Ikuko Tsukamoto. Effects of monosaccharides including rare sugars on proliferation of Entamoeba histolytica trophozoites in vitro. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1288470
|
3 |
Anjali Malik, Vikram Dalal, Serge Ankri, Shailly Tomar. Structural insights into Entamoeba histolytica arginase and structure‐based identification of novel non‐amino acid based inhibitors as potential antiamoebic molecules. The FEBS Journal 2019; 286(20): 4135 doi: 10.1111/febs.14960
|
4 |
Lotem Sarid, Eva Zanditenas, Jun Ye, Meirav Trebicz-Geffen, Serge Ankri. Insights into the Mechanisms of Lactobacillus acidophilus Activity against Entamoeba histolytica by Using Thiol Redox Proteomics. Antioxidants 2022; 11(5): 814 doi: 10.3390/antiox11050814
|
5 |
Helena Lucia Carneiro Santos, Karina M. Rebello. An Overview of Mucosa-Associated Protozoa: Challenges in Chemotherapy and Future Perspectives. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.860442
|
6 |
Shruti Nagaraja, Serge Ankri. Target identification and intervention strategies against amebiasis. Drug Resistance Updates 2019; 44: 1 doi: 10.1016/j.drup.2019.04.003
|
7 |
Gretter González-Blanco, Guillermina García-Rivera, Patricia Talmás-Rohana, Ester Orozco, José Manuel Galindo-Rosales, Cristina Vélez, Odila Salucedo-Cárdenas, Elisa Azuara-Liceaga, Mario Alberto Rodríguez-Rodríguez, Tomoyoshi Nozaki, Jesús Valdés. An Unusual U2AF2 Inhibits Splicing and Attenuates the Virulence of the Human Protozoan Parasite Entamoeba histolytica. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.888428
|